acgt.us | ACGT | Advanced Canine Genetic

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.acgt.us/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	ACGT \| Advanced Canine Genetic
Description	A discovery that ACGT made in dogs may be transformative for human cancer. We discovered that dogs Naturasone™, a natural product showing exciting preliminary results in canine cancer clinical trials. Contact us for admission into one of our trials
Keywords	ACGT, Canine Cancer, Dog Cancer, Dog Clinical Trial

Server Information

WebSite	acgt.us
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

acgt.us Valuation

US$721,719

Last updated: 2023-05-14 10:09:39

acgt.us has Semrush global rank of 14,665,418. acgt.us has an estimated worth of US$ 721,719, based on its estimated Ads revenue. acgt.us receives approximately 83,276 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, acgt.us is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$721,719
Daily Ads Revenue	US$667
Monthly Ads Revenue	US$19,987
Yearly Ads Revenue	US$239,833
Daily Unique Visitors	5,552
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
acgt.us.	A	3600	IP: 185.230.63.171
acgt.us.	A	3600	IP: 185.230.63.186
acgt.us.	A	3600	IP: 185.230.63.107
acgt.us.	NS	86400	NS Record: ns1.wixdns.net.
acgt.us.	NS	86400	NS Record: ns0.wixdns.net.
acgt.us.	MX	3600	MX Record: 30 alt2.aspmx.l.google.com.
acgt.us.	MX	3600	MX Record: 10 aspmx.l.google.com.
acgt.us.	MX	3600	MX Record: 40 aspmx2.googlemail.com.
acgt.us.	MX	3600	MX Record: 20 alt1.aspmx.l.google.com.
acgt.us.	MX	3600	MX Record: 50 aspmx3.googlemail.com.
acgt.us.	TXT	3600	TXT Record: google-site-verification=31Xp4w4KoOZ5HcAuzwbgHoMMVEqOkTLBeJ2Pl0fJUpM

HtmlToTextCheckTime:2023-05-14 10:09:39

top of page A New Approach to Cancer Transcriptome Analysis Discovery Research ACGT 011 ACGT 101, Lung Tumors ACGT 409, Mast Cell Tumors Contact The answer to cancer may be walking right beside us (PBS) Doberman Karma entered ACGT 011 research protocol in November 2015 Over the past 27 years, survival of cancer patients has improved only 7%. We believe that the use of mice and rats as model systems accounts for this dismal performance. They do not possess any element of the human-specific kill switch tumor suppression system. Consequently, for the past 40 years and more, we have been inventing drugs to treat mouse cancer, not human cancer. Furthermore, our progress treating cancer is approaching an asymptotic limit beyond which further improvement in survival may be impossible. Instead of "cure," normalization of lifetime cancer risk from its current 40% to the 4% of other long-lived animals should be our goal. Our discovery of the human-specific kill switch tumor suppression

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Thu, 23 Dec 2021 06:06:40 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.acgt.us/
strict-transport-security: max-age=120
x-wix-request-id: 1640239600.1491351740023715156
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=96
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgwC+Ai4EOpSUKUWvD0pOVz,m0j2EEknGIVUW/liY8BLLhyXxKyK6x8zVbaPNPNG03gXK4CpcIIKXm19QkScmIm+,2d58ifebGbosy5xc+FRalkAfDeLmhzk2SCpyA2aOnFUChNQZ50w2RxZ/ieHnWg6P4z38cifC9dXh8ONSUDZSjg==,2UNV7KOq4oGjA5+PKsX47Kj5xS9GJ8buECqoMUuwZrxYgeUJqUXtid+86vZww+nL,uBCfV4K61vt9PmVdWn+HHlC2MUSsFMqN5LxXclEF8efwcXiCJjelMQdweukbvEnQ,LZvWMb9Ine1rBayNYHr6PpHt2bK2pGKT4ErivaMdrHKTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,UCcefuQCi27dXmJSD6Vpi97cjJJuIJ1q795zPti402RdIAxUaz02F78CPhdy6VVrSYblWJ1+I4NCiXX+q5JMPA==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Thu, 23 Dec 2021 06:06:40 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1640239600.54613522889765427065
content-language: en
strict-transport-security: max-age=120
age: 0
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=96; Max-Age=20; Expires=Thu, 23 Dec 2021 06:07:00 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=96
x-seen-by: wmgbEcS9zOENaefw7bU4YXNkftjwE+Pu5FJ9u9rgJNk=,gv/XVF9HsGpk8A2KWukUzCWfEJXUOf1J0Ah0dFlolkk=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVjbiZiDDu8szEa1o3lFLyBE,m0j2EEknGIVUW/liY8BLLl+26s6ugfrJbuz2q1q9ImAqMJYpql10WU4QQPFwajBr,2d58ifebGbosy5xc+FRalrzHPVr5a+VE1EFwSI8/HmMexE3VGQcuLzrXisW/SiHohJ2ud1yx72wQ8CtFMAQftQ==,2UNV7KOq4oGjA5+PKsX47HPF/K3TcWAb94CYwN/9lZ5YgeUJqUXtid+86vZww+nL,uBCfV4K61vt9PmVdWn+HHtdLSHOO6cjEaMlYERA3oavwcXiCJjelMQdweukbvEnQ,/bCRknE/9SCmwHfJGMjlRsYwWnJTI2sMd++5oVqFwTFNG+KuK+VIZfbNzHJu0vJu,UCcefuQCi27dXmJSD6Vpiz3nP3TKFur+jDJV1DJQhEE7smmUQ+997D4RBKPGOAZqWIHlCalF7YnfvOr2cMPpyw==,/bCRknE/9SCmwHfJGMjlRsYwWnJTI2sMd++5oVqFwTFNG+KuK+VIZfbNzHJu0vJu,LoUK8/saGAmOxZWtpubo2kaWNmDD2xb4eeNtRuhykvzp8LwoNCIM6VDGkPNGlc0o0lJeO1cILWYU/2hVfWXmJA==,Q9UWnhMpT5TCWggv9Nmu7mB3k0Qs0fhO9MipJ6VWB9eTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,X5dRh+rzcwmxSuOfFJGa+15RjkQx4XoWpOABf/T3tTdXz5t7NzGxeu2CXkk1aB7ZGlsroP2XR0N+rjgJK/PU9A==,/a5ccLSK1HEmwPNg/x6OukIT+c5HqyHveWvXmN7dchrgwfZcRhLfsqahLp2ujgx8Ayd3B3AxYzR//ZaCyH7QuaUGavk3W79Lxd4PAGKcyfs=
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-content-type-options: nosniff
set-cookie: TS01e85bed=01b84e286ababecd4294d0813c52751cd67bae3c2fcc4f792b9bd36be1983ec0cb1a05c02223ebf51d0478d33c8489fe328eeeb96ab53967479022c40808926c96096c3f7a; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

acgt.us Whois Information

Domain Name: acgt.us
Registry Domain ID: D40887979-US
Registrar WHOIS Server: whois.opensrs.net
Registrar URL: www.opensrs.com
Updated Date: 2021-06-04T03:58:53Z
Creation Date: 2013-06-28T13:58:47Z
Registry Expiry Date: 2022-06-27T23:59:59Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email: compliance@tucows.com
Registrar Abuse Contact Phone: +1.4165350123
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID: C53428251-US
Registrant Name: Dr. Nyce
Registrant Organization: acgt
Registrant Street: P.O. Box 222
Registrant City: Fairview Village
Registrant State/Province: PA
Registrant Postal Code: 19409
Registrant Country: US
Registrant Phone: +1.4842551319
Registrant Email: cancerprofessor@yahoo.com
Registrant Application Purpose: P1
Registrant Nexus Category: C11
Registry Admin ID: C53428252-US
Admin Name: Dr. Nyce
Admin Organization: acgt
Admin Street: P.O. Box 222
Admin City: Fairview Village
Admin State/Province: PA
Admin Postal Code: 19409
Admin Country: US
Admin Phone: +1.4842551319
Admin Email: cancerprofessor@yahoo.com
Registry Tech ID: C53428253-US
Tech Name: YahooDomains TechContact
Tech Organization: Yahoo! Inc
Tech Street: 701 First Ave.
Tech City: Sunnyvale
Tech State/Province: CA
Tech Postal Code: 94089
Tech Country: US
Tech Phone: +1.4089162124
Tech Email: domain.tech@yahoo-inc.com
Name Server: ns0.wixdns.net
Name Server: ns1.wixdns.net
DNSSEC: unsigned
>>> Last update of WHOIS database: 2022-03-14T20:37:27Z <<<

acgt.us valuation and analysis